Thursday, July 3, 2025 7/3/2025

The Role of Macrophages in Vesicant Skin Injury and Repair

Award Number: R34AR081456
ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/13/2023
PERIOD OF PERFORMANCE END DATE: 03/31/2026

Group Awards By:

View Award Description

The Role of Macrophages in Vesicant Skin Injury and Repair - Abstract Chemical warfare agents such as mustards and arsenicals cause skin damage characterized by erythema, inflammation, and skin blistering, followed by a prolonged healing period. Although inflammatory cells and related cytokines are known to be increased in skin exposed to both mustards and arsenicals, similarities and differences in the roles of subsets of these cells in mustard- or arsenical-induced skin damage, as well as subsequent healing, remain to be elucidated. A goal of this proposal is to develop capacity to study the role of the inflammatory response, particularly the macrophage response, using cutting edge single cell techniques, in mustard and arsenical skin injury. This will include generating preliminary data with prototype agents and planning for experiments with restricted agents to support future NIH CounterACT grant submissions in the following aims: for Specific Aim 1, we will define the response of wound inflammatory cell subsets to vesicant skin injury using nitrogen mustard (NM) as prototype mustard and phenylarsine oxide (PAO) as prototype arsenical. For Specific Aim 2, since we and others have identified NLRP-3 is a key regulator of the inflammatory response to skin injury, we will determine the role of the NOD-Like Receptor (NLRP)-3 inflammasome in vesicant skin injury and repair. For Specific Aim 3, we will develop a relationship with MRIGlobal to perform studies with restricted vesicants. MRIGlobal is a contract research organization whose laboratory is approved for use of more potent restricted vesicants. Successful completion of this project will 1) bring a new skin wound healing research group into the chemical countermeasure field, 2) improve understanding of the role of inflammatory cell subsets in the response to vesicant injury, 3) establish the importance of the NLRP-3 inflammasome in regulating this inflammatory response and test an NLRP-3 inhibitor as a potential countermeasure and 4) develop a relationship with MRIGlobal for future studies using restricted vesicants. Ultimately, we plan to use knowledge generated by our research to develop novel countermeasures that target the inflammatory response.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $236,745 )
2025	2025	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD AVE M/C 551	CHICAGO	IL	60612	COOK	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	3	4/4/2025	NON-COMPETING CONTINUATION	$236,745
														Subtotal = $236,745

Issue Date FY: 2024 ( Subtotal = $236,835 )
2024	2024	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD AVE M/C 551	CHICAGO	IL	60612	COOK	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	2	3/12/2024	NON-COMPETING CONTINUATION	$236,835
														Subtotal = $236,835

Issue Date FY: 2023 ( Subtotal = $236,923 )
2023	2023	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD AVE M/C 551	CHICAGO	IL	60612	COOK	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	6/12/2023	NEW	$236,923
														Subtotal = $236,923

Grand Total All Awards = $710,503

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The Role of Macrophages in Vesicant Skin Injury and Repair

Award Number: R34AR081456

ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/13/2023

PERIOD OF PERFORMANCE END DATE: 03/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer